Does SACITUZUMAB GOVITECAN-HZIY Cause Hepatic function abnormal? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Hepatic function abnormal have been filed in association with SACITUZUMAB GOVITECAN-HZIY. This represents 0.5% of all adverse event reports for SACITUZUMAB GOVITECAN-HZIY.
17
Reports of Hepatic function abnormal with SACITUZUMAB GOVITECAN-HZIY
0.5%
of all SACITUZUMAB GOVITECAN-HZIY reports
4
Deaths
3
Hospitalizations
How Dangerous Is Hepatic function abnormal From SACITUZUMAB GOVITECAN-HZIY?
Of the 17 reports, 4 (23.5%) resulted in death, 3 (17.6%) required hospitalization.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SACITUZUMAB GOVITECAN-HZIY. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does SACITUZUMAB GOVITECAN-HZIY Cause?
Disease progression (1,068)
Death (483)
Diarrhoea (427)
Neutropenia (408)
Inappropriate schedule of product administration (217)
Fatigue (211)
Nausea (201)
Off label use (180)
Asthenia (171)
Alopecia (156)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which SACITUZUMAB GOVITECAN-HZIY Alternatives Have Lower Hepatic function abnormal Risk?
SACITUZUMAB GOVITECAN-HZIY vs SACROSIDASE
SACITUZUMAB GOVITECAN-HZIY vs SACUBITRIL
SACITUZUMAB GOVITECAN-HZIY vs SACUBITRIL\VALSARTAN
SACITUZUMAB GOVITECAN-HZIY vs SAFINAMIDE
SACITUZUMAB GOVITECAN-HZIY vs SAIZEN